Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Eli Lilly Australia Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (71)
Cancellation by sponsor (67)
Australian public assessment report (AusPar) (20)
Prescription medicine registration (20)
Designation or determination (4)
Prescription medicine evaluation (4)
Prescription medicine decision summary (3)

Date

2025 (30)
2024 (21)
2023 (21)
2022 (15)
2021 (10)
2020 (4)
2019 (34)
2018 (14)
2017 (1)
2016 (2)
2015 (7)
2014 (2)
2013 (4)
2012 (1)
2011 (2)
2010 (1)
2008 (2)
2007 (1)
2006 (1)
2004 (1)
2002 (2)
1999 (4)
1998 (1)
1996 (2)
1992 (4)
1991 (2)

Search

Sponsor content

189 result(s) found, displaying 151 to 160

Eli Lilly Australia Pty Limited - Cover Cancelled under Section 41GL(d) of the Act

23 February 2018

Cancellation by sponsor

Requested by Eli Lilly Australia Pty Ltd
Eli Lilly Australia Pty Limited - Injector, medication/vaccine, needle Cancelled under Section 41GL(d) of the Act

23 February 2018

Cancellation by sponsor

Requested by Eli Lilly Australia Pty Ltd
Eli Lilly Australia Pty Limited - Insuin injection kit - Injector, medication/vaccine, needle Cancelled under Section 41GL(d) of the Act

23 February 2018

Cancellation by sponsor

Requested by Eli Lilly Australia Pty Ltd
Notice for olaratumab (rmc) (Eli Lilly Australia Pty Ltd)

9 February 2018

Designation or determination

Orphan drug
BASAGLAR KwikPen insulin glargine (rbe) 100 IU/mL solution for injection cartridge (215552)

21 November 2014

ARTG

Australian Register of Therapeutic Goods (ARTG) information for BASAGLAR KwikPen insulin glargine (rbe) 100 IU/mL solution for injection cartridge.
BASAGLAR insulin glargine (rbe) 100 IU/mL solution for injection cartridge (215551)

21 November 2014

ARTG

Australian Register of Therapeutic Goods (ARTG) information for BASAGLAR insulin glargine (rbe) 100 IU/mL solution for injection cartridge.
OLUMIANT (Eli Lilly Australia Pty Ltd)

19 January 2018

Prescription medicine registration

Active ingredients: baricitinib.
AusPAR: Ixekizumab

23 May 2017

Australian public assessment report (AusPar)

Australian Public Assessment Report for Ixekizumab
DULOXETINE LY duloxetine 30 mg (as hydrochloride) enteric capsule blister pack Cancelled under s30(1)(c )

4 September 2015

Cancellation by sponsor

Requested by Eli Lilly Australia Pty Ltd
DULOXETINE LY duloxetine 60 mg (as hydrochloride) enteric capsule blister pack Cancelled under s30(1)(c )

4 September 2015

Cancellation by sponsor

Requested by Eli Lilly Australia Pty Ltd

Pages

First page
Previous page
…
Page 11
Page 12
Page 13
Page 14
Page 15
Current page 16
Page 17
Page 18
Page 19
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.